Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04226950
What this trial is testing

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

Who this might be right for
Essential Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 40
Large-scale testing (Phase 3)UnknownNCT05808322
What this trial is testing

Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities

Who this might be right for
COVID-19
National Taiwan University Hospital 60
Not applicableLooking for participantsNCT06881056
What this trial is testing

Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia

Who this might be right for
Respiratory Syncytial Virus (RSV)
West China Second University Hospital 90
Large-scale testing (Phase 3)Study completedNCT00781274
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 32
Large-scale testing (Phase 3)Study completedNCT00780910
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 109
Testing effectiveness (Phase 2)Ended earlyNCT00415857
What this trial is testing

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00006039
What this trial is testing

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01710501
What this trial is testing

Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Who this might be right for
Chronic Hepatitis C (CHC)
Merck Sharp & Dohme LLC 87
Not applicableUnknownNCT03771677
What this trial is testing

To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.

Who this might be right for
Hepatitis B
Sun Yat-sen University 400
Post-approval studies (Phase 4)Study completedNCT01532843
What this trial is testing

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB

Who this might be right for
Chronic Hepatitis B
Foundation for Liver Research 82
Not applicableStudy completedNCT01007058
What this trial is testing

Markers of Response to Intravesical Bladder Cancer Therapy

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 150
Large-scale testing (Phase 3)Study completedNCT01581398
What this trial is testing

Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Xiamen Amoytop Biotech Co., Ltd. 770
Large-scale testing (Phase 3)Study completedNCT00323804
What this trial is testing

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Who this might be right for
Hepatitis C, ChronicLiver Fibrosis
ANRS, Emerging Infectious Diseases 372
Early research (Phase 1)Ended earlyNCT02948426
What this trial is testing

Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
National Cancer Institute (NCI) 18
Post-approval studies (Phase 4)UnknownNCT03332329
What this trial is testing

Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Qin Ning 15
Large-scale testing (Phase 3)Active Not RecruitingNCT02506153
What this trial is testing

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+6 more
National Cancer Institute (NCI) 1,301
Testing effectiveness (Phase 2)Study completedNCT00759200
What this trial is testing

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Novartis 525
Testing effectiveness (Phase 2)Ended earlyNCT00090870
What this trial is testing

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 10
Large-scale testing (Phase 3)Active Not RecruitingNCT00003641
What this trial is testing

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,150
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Next Page